Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 0.0 | 0.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.39 | 2 |
NAV | ₹9.29 | ₹62.31 |
Fund Started | 07 Dec 2020 | 18 Jun 2012 |
Fund Size | ₹52.28 Cr | ₹3228.15 Cr |
Exit Load | Exit load for units in excess of 8% of the investment,1% will be charged for redemption within 365 days | Exit load of 1% if redeemed within 1 month. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -1.84% | 11.74% |
3 Year | -2.39% | 9.95% |
5 Year | - | 13.98% |
1 Year
3 Year
5 Year
Equity | 0.00% | 98.03% |
Cash | 100.00% | 1.97% |
Equity
Cash
Top 10 Holdings | - |
|
Top 10 Holdings
Name | Assets |
---|---|
Gilead Sciences Inc. (USA) | 2.79% |
The Walt Disney Company | 2.74% |
Altria Group Inc | 2.69% |
Bristol-Myers Squibb Co | 2.62% |
The Boeing Co | 2.52% |
Corteva Inc. | 2.49% |
Bio-Rad Laboratories Inc A | 2.47% |
U.S. Bancorp | 2.46% |
Autodesk Inc. (USA) | 2.44% |
Kenvue Inc. | 2.40% |
Name | Arjun Khanna | Ritesh Lunawat |
Start Date | 25 Oct 2023 | 28 Dec 2020 |
Name
Start Date
Description | The scheme seeks to provide long-term capital appreciation and income by investing in units of SMAM ASIA REIT Sub Trust fund and/or other similar overseas REIT funds. | The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies. |
Launch Date | 07 Dec 2020 | 18 Jun 2012 |
Description
Launch Date